The U.S. Senate passed two highly anticipated, bipartisan bills on Thursday aimed at removing systemic barriers for pilots and air traffic controllers seeking mental health treatment.
Sponsored by Sens. John Hoeven (R-N.D.) and Tammy Duckworth (D-Ill.), the legislation passed the upper chamber by unanimous consent. The sweeping reforms are designed to dismantle an archaic regulatory culture that aviation advocates argue forces pilots to hide their psychological struggles out of fear of losing their medical clearances and, subsequently, their careers.
The John A. Hauser Act and Medical Reform
The first piece of the legislative package is the John A. Hauser Mental Health in Aviation Act (MHAA).
The bill is named in honor of a University of North Dakota aviation student who tragically took his own life in an airplane crash in 2021 after concealing his mental health struggles. According to the Pilot Mental Health Campaign (PMHC), which heavily advocated for the reforms, the current Federal Aviation Administration (FAA) medical certification process can often leave pilots who report seeking therapy or mental health care grounded for more than a year.
The MHAA seeks to fix this by accelerating the FAA’s medical approval process, expanding peer-support programs that train pilots to confidentially discuss concerns, and mandating an annual review of the FAA’s Special Issuance Medical Certification process. Furthermore, the legislation authorizes $15 million annually over four years to the Office of Aerospace Medicine to increase funding for aeromedical examiners and specialized training, plus an additional $1.5 million for a public information campaign to reduce stigma.
Providing Clarity on Medications
The second measure passed Thursday is the Aviation Medication Transparency Act (AMTA).
For years, pilots and medical providers have struggled with a lack of clarity regarding which specific prescription medications—particularly those used to treat depression or anxiety—are permitted by the FAA. The AMTA requires the FAA to publish a comprehensive, annually updated list of medications officially designated as “can be safely prescribed,” “Do Not Issue,” or “Do Not Fly” within one year of the bill’s enactment.
Industry leaders lauded the passage of the bills, characterizing them as a monumental shift for aviation safety. The National Air Traffic Controllers Association (NATCA) noted that the current system “perpetuates a culture of silence and stigma that must be addressed”.
The U.S. House of Representatives previously passed its version of the MHAA earlier this year, and the House Transportation and Infrastructure Committee recently advanced its variant of the AMTA. Both bills will now need to be fully reconciled in the House before heading to the president’s desk to become law.


